Health
Roche and Sanofi Seek Ways to Sidestep Potential Trump Tariffs
This article is for subscribers only.
Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s potential tariffs.
Switzerland’s Roche Holding AG is moving production for some medicines as well as building inventory in the US and China. And Sanofi is considering more manufacturing investments in the US, where it makes almost half of its sales, a day after France softened its approach to the trade clash with Trump.